Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2013 1
2015 1
2017 2
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
What makes resistance to methicillin heterogeneous?
Rohrer S, Maki H, Berger-Bächi B. Rohrer S, et al. J Med Microbiol. 2003 Aug;52(Pt 8):605-607. doi: 10.1099/jmm.0.05176-0. J Med Microbiol. 2003. PMID: 12867551 Free article. No abstract available.
Factors influencing methicillin resistance in staphylococci.
Berger-Bächi B, Rohrer S. Berger-Bächi B, et al. Among authors: rohrer s. Arch Microbiol. 2002 Sep;178(3):165-71. doi: 10.1007/s00203-002-0436-0. Epub 2002 Jun 19. Arch Microbiol. 2002. PMID: 12189417 Review.
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials.
Dougados M, Kiltz U, Kivitz A, Pavelka K, Rohrer S, McCreddin S, Quebe-Fehling E, Porter B, Talloczy Z. Dougados M, et al. Among authors: rohrer s. Rheumatol Int. 2022 Feb;42(2):205-213. doi: 10.1007/s00296-021-05044-6. Epub 2021 Nov 13. Rheumatol Int. 2022. PMID: 34773130 Clinical Trial.
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study.
Pavelka K, Kivitz AJ, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, Wang Y, Porter BO, Stefanska A, Richards HB, Rohrer S; MEASURE 3 study group. Pavelka K, et al. Among authors: rohrer s. ACR Open Rheumatol. 2020 Feb;2(2):119-127. doi: 10.1002/acr2.11102. Epub 2020 Jan 20. ACR Open Rheumatol. 2020. PMID: 31957970 Free PMC article.
11 results